{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:29:39Z","timestamp":1784550579166,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13054-017-1862-3","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T15:41:45Z","timestamp":1509464505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study"],"prefix":"10.1186","volume":"21","author":[{"given":"Eleni","family":"Palli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demosthenes","family":"Makris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Papanikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios","family":"Garoufalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irini","family":"Tsilioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paris","family":"Zygoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Epaminondas","family":"Zakynthinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,31]]},"reference":[{"issue":"21","key":"1862_CR1","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM199411243312111","volume":"331","author":"BJ Barrett","year":"1994","unstructured":"Barrett BJ, Parfrey PS. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med. 1994;331(21):1449\u201350.","journal-title":"N Engl J Med"},{"key":"1862_CR2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","volume":"103","author":"PA McCullough","year":"1997","unstructured":"McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368\u201375.","journal-title":"Am J Med"},{"key":"1862_CR3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(83)90618-6","volume":"74","author":"SH Hou","year":"1983","unstructured":"Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med. 1983;74:243\u20138.","journal-title":"Am J Med"},{"key":"1862_CR4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3111\/200710119134","volume":"10","author":"S Subramanian","year":"2007","unstructured":"Subramanian S, Tumlin J, Bapat B, et al. Economic burden of contrast-induced nephropathy: implications for prevention strategies. J Med Econ. 2007;10:119\u201334.","journal-title":"J Med Econ"},{"key":"1862_CR5","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2215\/CJN.00550109","volume":"4","author":"RJ Solomon","year":"2009","unstructured":"Solomon RJ, Mehran R, Natarajan MK, et al. Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol. 2009;4:1162\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1862_CR6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000151772","volume":"29","author":"I Goldenberg","year":"2009","unstructured":"Goldenberg I, Chonchol M, Guetta V. Reversible acute kidney injury following contrast exposure and the risk of longterm mortality. Am J Nephrol. 2009;29:136\u201344.","journal-title":"Am J Nephrol"},{"key":"1862_CR7","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.amjcard.2004.03.008","volume":"93","author":"BA Bartholomew","year":"2004","unstructured":"Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93:1515\u20139.","journal-title":"Am J Cardiol"},{"key":"1862_CR8","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0735-1097(00)00917-7","volume":"36","author":"L Gruberg","year":"2000","unstructured":"Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36:1542\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1862_CR9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0002-9343(90)90180-L","volume":"89","author":"CL Manske","year":"1990","unstructured":"Manske CL, Sprafka JM, Strony JT, et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med. 1990;89:615\u201320.","journal-title":"Am J Med"},{"key":"1862_CR10","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/archinte.1990.00390180067011","volume":"150","author":"MW Rich","year":"1990","unstructured":"Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med. 1990;150:1237\u201342.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1862_CR11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1540-8183.2012.00767.x","volume":"26","author":"MA Albabtain","year":"2013","unstructured":"Albabtain MA, Almasood A, Alshurafah H, et al. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-induced nephropathy: a prospective randomized study. J Interv Cardiol. 2013;26(1):90\u20136.","journal-title":"J Interv Cardiol"},{"key":"1862_CR12","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/01.CIR.0000146396.19081.73","volume":"110","author":"K Spargias","year":"2004","unstructured":"Spargias K, Alexopoulos E, Kyrzopoulos S, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation. 2004;110:2837\u201342.","journal-title":"Circulation"},{"issue":"8","key":"1862_CR13","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00134-006-0198-2","volume":"32","author":"JW Haveman","year":"2006","unstructured":"Haveman JW, Gansevoort RT, Bongaerts AH, et al. Low incidence of nephropathy in surgical ICU patients receiving intravenous contrast: a retrospective analysis. Intensive Care Med. 2006;32(8):1199\u2013205.","journal-title":"Intensive Care Med"},{"issue":"5","key":"1862_CR14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jcrc.2013.03.007","volume":"28","author":"BG Chousterman","year":"2013","unstructured":"Chousterman BG, Bouadma L, Moutereau S, et al. Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results. J Crit Care. 2013;28(5):701\u20139.","journal-title":"J Crit Care"},{"key":"1862_CR15","first-page":"1393","volume":"44","author":"R Mehran","year":"2004","unstructured":"Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1862_CR16","doi-asserted-by":"crossref","first-page":"756469","DOI":"10.1155\/2014\/756469","volume":"2014","author":"E Palli","year":"2014","unstructured":"Palli E, Makris D, Papanikolaou J, et al. Contrast-induced nephropathy in aged critically ill patients. Oxid Med Cell Longev. 2014;2014:756469.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"1862_CR17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/ajkd.1998.v32.pm9669426","volume":"32","author":"RE Katholi","year":"1998","unstructured":"Katholi RE, Woods Jr WT, Taylor GJ, et al. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis. 1998;32(1):64\u201371.","journal-title":"Am J Kidney Dis"},{"key":"1862_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ki.1994.32","volume":"45","author":"LS Weisberg","year":"1994","unstructured":"Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int. 1994;45:259\u201365.","journal-title":"Kidney Int"},{"key":"1862_CR19","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1007\/s00134-011-2393-z","volume":"37","author":"M Joannidis","year":"2011","unstructured":"Joannidis M, Wiedermann C. Radiocontrast-induced acute kidney injury in the ICU: worse than presumed? Intensive Care Med. 2011;37:1904\u20136.","journal-title":"Intensive Care Med"},{"key":"1862_CR20","first-page":"337","volume":"12","author":"J Kay","year":"2003","unstructured":"Kay J, Chow WH, Chan TM. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention. A randomized controlled clinical trial. ACC Curr J Rev. 2003;12:337\u20138.","journal-title":"ACC Curr J Rev"},{"key":"1862_CR21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1523-1755.2005.00377.x","volume":"68","author":"PB Persson","year":"2005","unstructured":"Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium induced nephropathy. Kidney Int. 2005;68:14\u201322.","journal-title":"Kidney Int"},{"key":"1862_CR22","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00134-016-4258-y","volume":"42","author":"M Wetterslev","year":"2016","unstructured":"Wetterslev M, M\u00f8ller-S\u00f8rensen H, Johansen RR, et al. Systematic review of cardiac output measurements by echocardiography vs. thermodilution: the techniques are not interchangeable. Intensive Care Med. 2016;42:1223\u201333.","journal-title":"Intensive Care Med"},{"issue":"2","key":"1862_CR23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijcard.2007.04.048","volume":"127","author":"H Bachorzewska-Gajewska","year":"2008","unstructured":"Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al. NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine? Int J Cardiol. 2008;127(2):290\u20131.","journal-title":"Int J Cardiol"},{"issue":"3","key":"1862_CR24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1523-1755.2004.00861.x","volume":"66","author":"S Herget-Rosenthal","year":"2004","unstructured":"Herget-Rosenthal S, Marggraf G, H\u00fcsing J, et al. Early detection of acute renal failure by serum cystatin. C Kidney Int. 2004;66(3):1115\u201322.","journal-title":"C Kidney Int"},{"issue":"23","key":"1862_CR25","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/eurheartj\/ehu063","volume":"35","author":"A Narula","year":"2014","unstructured":"Narula A, Mehran R, Weisz G, et al. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. Eur Heart J. 2014;35(23):1533\u201340.","journal-title":"Eur Heart J"},{"key":"1862_CR26","doi-asserted-by":"crossref","unstructured":"Tumlin J, Stacul F, Adam A, et al. Pathophysiology of contrast induced nephropathy. Am J Cardiol. 2006;18:98(6A):14K\u201320K. Epub 2006 Feb 17.","DOI":"10.1016\/j.amjcard.2006.01.020"},{"issue":"10076","key":"1862_CR27","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(17)30540-8","volume":"389","author":"PA McCullough","year":"2017","unstructured":"McCullough PA, Zhang J, Ronco C. Volume expansion and contrast-induced acute kidney injury. Lancet. 2017;389(10076):1277\u20138. https:\/\/doi.org\/10.1007\/s80109000008610.1016\/S0140-6736(17)30540-8 Epub 2017 Feb 21.","journal-title":"Lancet"},{"issue":"2","key":"1862_CR28","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1373\/clinchem.2011.170464","volume":"58","author":"F Ribichini","year":"2012","unstructured":"Ribichini F, Gambaro G, Graziani MS, et al. Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. Clin Chem. 2012;58(2):458\u201364.","journal-title":"Clin Chem"},{"issue":"4","key":"1862_CR29","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/CCM.0b013e318275871a","volume":"41","author":"S Ehrmann","year":"2013","unstructured":"Ehrmann S, Badin J, Savath L, et al. Acute kidney injury in the critically ill: is iodinated contrast medium really harmful? Crit Care Med. 2013;41(4):1017\u201326.","journal-title":"Crit Care Med"},{"issue":"6","key":"1862_CR30","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1177\/0310057X0903700613","volume":"37","author":"AH Rashid","year":"2009","unstructured":"Rashid AH, Brieva JL, Strokes B. Incidence of contrast induced nephropathy in intensive care patients undergoing computerised tomography and prevalence of risk factors. Anaesth Intensive Care. 2009;37(6):968\u201375.","journal-title":"Anaesth Intensive Care"},{"issue":"10","key":"1862_CR31","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/clinchem\/38.10.1933","volume":"38","author":"RD Perrone","year":"1992","unstructured":"Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992;38(10):1933\u201353.","journal-title":"Clin Chem"},{"issue":"3","key":"1862_CR32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1755-5922.2011.00309.x","volume":"31","author":"E Alioglou","year":"2013","unstructured":"Alioglou E, Saygi S, Turk U, et al. N-acetylcysteine in preventing contrast-induced nephropathy assessed by cystatin C. Cardiovasc Ther. 2013;31(3):168\u201373.","journal-title":"Cardiovasc Ther"},{"key":"1862_CR33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1515\/CCLM.1999.064","volume":"37","author":"E Randers","year":"1999","unstructured":"Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function\u2014a review. Clin Chem Lab Med. 1999;37:389\u201395.","journal-title":"Clin Chem Lab Med"},{"key":"1862_CR34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ki.1995.40","volume":"47","author":"DJ Newman","year":"1995","unstructured":"Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 1995;47:312\u20138.","journal-title":"Kidney Int"},{"issue":"8","key":"1862_CR35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/clc.22551","volume":"39","author":"N Kafkas","year":"2016","unstructured":"Kafkas N, Liakos C, Zoubouloglou F, et al. Neutrophil gelatinase-associated lipocalin as an early marker of contrast-induced nephropathy after elective invasive cardiac procedures. Clin Cardiol. 2016;39(8):464\u201370.","journal-title":"Clin Cardiol"},{"issue":"3","key":"1862_CR36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4103\/1119-3077.130240","volume":"17","author":"BS Tiryaki","year":"2014","unstructured":"Tiryaki BS, Tasliyurt T, Yelken BM, et al. Evaluation of oxidative stress using exhaled breath 8-isoprostane levels on chronic kidney disease. Niger J Clin Pract. 2014;17(3):356\u201360.","journal-title":"Niger J Clin Pract"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-017-1862-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T22:01:20Z","timestamp":1603231280000},"score":1,"resource":{"primary":{"URL":"http:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-017-1862-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,31]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1862"],"URL":"https:\/\/doi.org\/10.1186\/s13054-017-1862-3","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,31]]},"article-number":"269"}}